These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 7070541)

  • 21. Clinical studies with naloxone/methadone in a ratio of 1:20.
    Bloom WA; Sudderth EW; Marcello L
    Proc Natl Conf Methadone Treat; 1973; 2():1342-9. PubMed ID: 4612372
    [No Abstract]   [Full Text] [Related]  

  • 22. Psychobiological responses to drug cues before and after methadone intake in heroin-dependent patients: a pilot study.
    Walter M; Wiesbeck GA; Bloch N; Aeschbach S; Olbrich HM; Seifritz E; Dürsteler-MacFarland KM
    Eur Neuropsychopharmacol; 2008 May; 18(5):390-3. PubMed ID: 18299189
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential regional effects of methadone maintenance compared to heroin dependence on mu-opioid receptor desensitization in rat brain.
    Martin TJ; Kahn WR; Xiao R; Childers SR
    Synapse; 2007 Mar; 61(3):176-84. PubMed ID: 17152089
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The quantitative analysis of heroin, methadone and their metabolites and the simultaneous detection of cocaine, acetylcodeine and their metabolites in human plasma by high-performance liquid chromatography coupled with tandem mass spectrometry.
    Rook EJ; Hillebrand MJ; Rosing H; van Ree JM; Beijnen JH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Sep; 824(1-2):213-21. PubMed ID: 16103023
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Iatrogenic methadone poisoning].
    Rabl W; Sigrist T; Sutter K
    Schweiz Rundsch Med Prax; 1993 Feb; 82(8):217-9. PubMed ID: 8441877
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Factors influencing the rate on retention to methadone maintenance treatment program among heroin addicts in Guizhou, China].
    Liang T; Liu EW; Zhong H; Wang B; Shen LM; Wu ZL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb; 30(2):131-5. PubMed ID: 19565871
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Risk factors associated with continued heroin use during methadone maintenance treatment in Guizhou province, China].
    Liu EW; Wu ZY; Liang T; Shen LM; Zhong H; Wang B; Roger D
    Zhonghua Yu Fang Yi Xue Za Zhi; 2008 Dec; 42(12):875-8. PubMed ID: 19141219
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Excretion of methadone and metabolites in human sweat.
    Henderson GL; Wilson BK
    Res Commun Chem Pathol Pharmacol; 1973 Jan; 5(1):1-8. PubMed ID: 4686102
    [No Abstract]   [Full Text] [Related]  

  • 29. Methadone doses of 100 mg or greater are more effective than lower doses at suppressing heroin self-administration in opioid-dependent volunteers.
    Donny EC; Brasser SM; Bigelow GE; Stitzer ML; Walsh SL
    Addiction; 2005 Oct; 100(10):1496-509. PubMed ID: 16185211
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Buprenorphine as maintenance treatment in rehabilitation of heroin addicts].
    Bramness JG; Bachs LC; Waal H
    Tidsskr Nor Laegeforen; 2002 Oct; 122(25):2452-4. PubMed ID: 12448114
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The current status of heroin prescription treatment for heroin dependence.
    Wodak A
    Expert Opin Drug Saf; 2005 Sep; 4(5):815-9. PubMed ID: 16111445
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Study on anxiety and depression status among the methadone maintenance treatment patients in Wuxi, Jiangsu].
    Gao Q; Cheng H; Feng JY; Wang B
    Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Mar; 29(3):308-9. PubMed ID: 18788538
    [No Abstract]   [Full Text] [Related]  

  • 33. [Use of a new drug in the treatment of heroin addicts should not be obstructed by political dogmatism].
    Heilig M; Nilsson LH; Grönbladh L; Thulin SO; Sternebring B
    Lakartidningen; 2001 Sep; 98(37):3956-8. PubMed ID: 11586837
    [No Abstract]   [Full Text] [Related]  

  • 34. Methadone plasma level: sustained by a reservoir of drug in tissue.
    Dole VP; Kreek MJ
    Proc Natl Acad Sci U S A; 1973 Jan; 70(1):10. PubMed ID: 4509643
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intravenous and intranasal heroin-dependent treatment-seekers: characteristics and treatment outcome.
    Highfield DA; Schwartz RP; Jaffe JH; O'Grady KE
    Addiction; 2007 Nov; 102(11):1816-23. PubMed ID: 17784892
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute effect of methadone maintenance dose on brain FMRI response to heroin-related cues.
    Langleben DD; Ruparel K; Elman I; Busch-Winokur S; Pratiwadi R; Loughead J; O'Brien CP; Childress AR
    Am J Psychiatry; 2008 Mar; 165(3):390-4. PubMed ID: 18056224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methadone maintenance treatment at Sisters of Charity, Buffalo.
    Dever MC; Boyd TJ
    Hosp Prog; 1974 Feb; 55(2):32-5. PubMed ID: 4811513
    [No Abstract]   [Full Text] [Related]  

  • 38. [Methadone maintenance: adoption of a new harm reduction approach in Hungary].
    Szabó L; Polgár P; Gerevich J
    Orv Hetil; 2005 Aug; 146(32):1685-91. PubMed ID: 16149246
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Matching of treatment-resistant heroin-dependent patients to medical prescription of heroin or oral methadone treatment: results from two randomized controlled trials.
    Blanken P; Hendriks VM; Koeter MW; van Ree JM; van den Brink W
    Addiction; 2005 Jan; 100(1):89-95. PubMed ID: 15598196
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Anticipated effects of experimental heroin prescription on the method of administration and the use of other drugs].
    Benschop A; Hendriks VM; Blanken P
    Ned Tijdschr Geneeskd; 1997 Feb; 141(6):292-5. PubMed ID: 9148165
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.